05:22 PM EDT, 03/25/2024 (MT Newswires) -- Ocular Therapeutix ( OCUL ) filed a shelf registration statement Monday with the US Securities and Exchange Commission covering the potential sale of up to 43,219,517 common shares of the company from time to time by certain stockholders in one or more offerings.

According to a regulatory filing, the statement includes 10,805,957 shares issuable upon the exercise of pre-funded warrants.

The company said it will not receive any proceeds from the share sale by the selling stockholders.

The company's shares were down 3.8% in after-hours activity.

Price: 9.05, Change: -0.36, Percent Change: -3.83